Abstract:Abstract Background Inherited vitreoretinopathies arise as a consequence of congenital retinal vascularisation abnormalities. They represent a phenotypically and genetically heterogeneous group of disorders that can have a major impact on vision. Several genes encoding proteins and effectors of the canonical Wnt/β-catenin pathway have been associated and precise diagnosis, although difficult, is essential for proper clinical management including syndrome specific management where appropriate. This work aimed to investigate the molecular basis of disease in a single proband born to consanguineous parents, who presented with microphthalmia, persistent foetal vasculature, posterior lens vacuoles, vitreoretinal dysplasia, microcephaly, hypotelorism and global developmental delay, and was registered severely visually impaired by 5 months of age. Methods Extensive genomic pre-screening, including microarray comparative genomic hybridisation and sequencing of a 114 gene panel associated with cataract and congenital ophthalmic disorders was conducted by an accredited clinical laboratory. Whole exome sequencing (WES) was undertaken on a research basis and in vitro TOPflash transcriptional reporter assay was utilised to assess the impact of the putative causal variant. Results In the proband, WES revealed a novel, likely pathogenic homozygous mutation in the cadherin-associated protein beta-1 gene ( CTNNB1), c.884C>G; p.(Ala295Gly), which encodes a co-effector molecule of the Wnt/β-catenin pathway. The proband’s parents were shown to be heterozygous carriers but ophthalmic examination did not detect any abnormalities. Functional assessment of the missense variant demonstrated significant reduction of β-catenin activity. Conclusions This is the first report of a biallelic disease-causing variation in CTNNB1 . We conclude that this biallelic, transcriptional inactivating mutation of CTNNB1 causes a severe, syndromic form of microphthalmia, persistent foetal vasculature and vitreoretinal dysplasia that results in serious visual loss in infancy.

Skeletal abnormalities, pediatric-onset severe osteoporosis, and multiple fragility fractures in a patient with a novel CTNNB1 de novo variant

Novel CTNNB1 variant leading to neurodevelopmental disorder with spastic diplegia and visual defects plus peripheral neuropathy: A case report

Identification of a novel splice mutation in CTNNB1 gene in a Chinese family with both severe intellectual disability and serious visual defects

Genetic and clinical characteristics of 24 mainland Chinese patients with <i>CTNNB1</i> loss-of-function variants

A novel de novo truncating variant in a Hungarian patient with CTNNB1 neurodevelopmental disorder

Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants

Exome Sequencing Identifies A De Novo Mutation Of Ctnnb1 Gene In A Patient Mainly Presented With Retinal Detachment, Lens And Vitreous Opacities, Microcephaly, And Developmental Delay

A Mosaic Variant in CTNNB1 /β-catenin as a Novel Cause for Osteopathia Striata With Cranial Sclerosis

Case report: Novel NUS1 variant in a Chinese patient with tremors and intellectual disability

De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum

Clinical phenotypic spectrum of CTNNB1 neurodevelopmental disorder

Case report: A novel truncating variant of BCL11B associated with rare feature of craniosynostosis and global developmental delay.

Germline Mutations in CTNNB1 Associated with Syndromic FEVR or Norrie Disease

De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features

A Recurrent Single‐exon Deletion in TBCK Might Be Under‐recognized in Patients with Infantile Hypotonia and Psychomotor Delay

Skeletal Characteristics of WNT1 Osteoporosis in Children and Young Adults

Molecular dissection of somatic skeletal disease in Neurofibromatosis Type 1

Bi-allelic mutation of CTNNB1 causes a severe form of syndromic microphthalmia, persistent foetal vasculature and vitreoretinal dysplasia

Patient with a heterozygous pathogenic variant in CSNK2A1 gene: A new case to update the Okur–Chung neurodevelopmental syndrome

Developmental epileptic encephalopathy with hypomyelination and brain atrophy associated with PTPN23 variants affecting the assembly of UsnRNPs

Clinical characteristics and identification of novel CNOT1 variants in three unrelated Chinese families with Vissers-Bodmer Syndrome